2021
DOI: 10.1016/j.bbi.2020.12.002
|View full text |Cite
|
Sign up to set email alerts
|

Acute neuroinflammation, sickness behavior and working memory responses to acute systemic LPS challenge following noradrenergic lesion in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(10 citation statements)
references
References 54 publications
0
10
0
Order By: Relevance
“…The increase in nucleotide release resulting from brain injury was shown to be involved in activation of microglial cells as well as in their chemotaxis by acting on purinergic receptor P2Y12 (P2ry12) [42]; the expression of P2ry12 was downregulated in response to both MCAO and LPS in our study. Significant decrease in hippocampal P2ry12 expression was found previously after microglial activation by systemic LPS administration [43]. It has been reported that P2Y12 receptor activation on microglia aggravates ischemic stroke injury [44].…”
Section: Inflammatory Responsementioning
confidence: 90%
“…The increase in nucleotide release resulting from brain injury was shown to be involved in activation of microglial cells as well as in their chemotaxis by acting on purinergic receptor P2Y12 (P2ry12) [42]; the expression of P2ry12 was downregulated in response to both MCAO and LPS in our study. Significant decrease in hippocampal P2ry12 expression was found previously after microglial activation by systemic LPS administration [43]. It has been reported that P2Y12 receptor activation on microglia aggravates ischemic stroke injury [44].…”
Section: Inflammatory Responsementioning
confidence: 90%
“…The locus coeruleus noradrenergic (LCNE) pathway has been proven to be involved in regulating a wide range of advanced cognitive functions ( Sara, 2009 ; Betts et al, 2019 ), such as working memory, learning and attention ( Robbins, 1984 ; Aston-Jones and Cohen, 2005 ; Mather et al, 2016 ), memory formation and consolidation ( Gibbs and Summers, 2002 ; Gibbs et al, 2010 ; Hansen, 2017 ), and immunological mechanisms in the brain ( Polak et al, 2011 ; Stowell et al, 2019 ). A few studies have shown that the LCNE pathway contributes to the pathomechanism of neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) ( Giorgi et al, 2020 ), and septic encephalopathy ( O’Neill et al, 2020 ), in which neuroinflammation plays an important role. In Termpanit’s study, the losses of LC fibers and noradrenaline (NE) exacerbate spatial learning and memory deficits in transgenic mouse models of AD, accompanied by the activation of microglia and astrocytes in the hippocampus ( Chalermpalanupap et al, 2018 ).…”
Section: Introductionmentioning
confidence: 99%
“…On days 7 and 14 before intestinal I/R injury, mice in the DSP-4 + I/R group were administered DSP-4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride, #C8417, Sigma-Aldrich Corporation, St Louis, MO, USA) at 50 mg/kg IP. The dose and timepoint of DSP-4 have been used in many previous studies [ 36 , 37 ]. Animals in the DSP-4 + DEX + I/R group received DSP-4 and then dexmedetomidine before intestinal I/R, and the dose and time points were the same as those in the DEX + I/R or DSP-4 + I/R groups.…”
Section: Methodsmentioning
confidence: 99%